Company SI-BONE, Inc. Deutsche Boerse AG

Equities

2K3

US8257041090

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 06:59:01 31/05/2024 pm IST 5-day change 1st Jan Change
12.3 EUR -.--% Intraday chart for SI-BONE, Inc. +0.82% -35.26%

Business Summary

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Number of employees: 344

Sales per Business

USD in Million2022Weight2023Weight Delta
Surgical Implant System
100.0 %
106 100.0 % 139 100.0 % +30.52%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
94.0 %
99 92.8 % 131 94.0 % +32.27%
International
6.0 %
8 7.2 % 8 6.0 % +7.93%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 26/15/26
Founder 69 18/08/18
Director of Finance/CFO 44 19/21/19
Chief Tech/Sci/R&D Officer 56 01/21/01
Chief Tech/Sci/R&D Officer - 01/21/01
Chief Tech/Sci/R&D Officer 62 01/12/01
Chief Operating Officer - 01/22/01
Chief Tech/Sci/R&D Officer - 01/12/01
Public Communications Contact 65 01/09/01
Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Founder 69 18/08/18
Director/Board Member 70 01/13/01
Director/Board Member 77 01/11/01
Director/Board Member 67 03/19/03
Chief Executive Officer 57 26/15/26
Director/Board Member 53 18/08/18
Director/Board Member 56 01/15/01
Director/Board Member 60 04/21/04
Director/Board Member 60 18/21/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 41,204,796 40,332,322 ( 97.88 %) 0 97.88 %

Shareholders

NameEquities%Valuation
Brown Investment Advisory & Trust Co.
10.28 %
4,223,342 10.28 % 60 M €
BlackRock Advisors LLC
9.072 %
3,725,398 9.072 % 53 M €
OrbiMed Advisors Private Equity
7.731 %
3,174,521 7.731 % 45 M €
First Light Asset Management LLC
6.023 %
2,473,165 6.023 % 35 M €
Vanguard Fiduciary Trust Co.
5.999 %
2,463,501 5.999 % 35 M €
Champlain Investment Partners LLC
5.974 %
2,453,147 5.974 % 35 M €
American Century Cos., Inc.
3.940 %
1,617,839 3.940 % 23 M €
Granahan Investment Management, LLC
3.878 %
1,592,574 3.878 % 23 M €
Bellevue Asset Management AG
2.776 %
1,139,956 2.776 % 16 M €
Paradigm Capital Management, Inc.
2.636 %
1,082,300 2.636 % 15 M €

Company contact information

SI-BONE, Inc.

471 El Camino Real Suite 101

95050, Santa Clara

+408 207 0700

http://www.si-bone.com
address SI-BONE, Inc.(2K3)

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.05 USD
Average target price
25.56 USD
Spread / Average Target
+81.89%
Consensus